Edge Bronchoscope Robot

Edge Product Family: Edge MP1000 (Multi-Port) | Edge SP1000 (Single-Port) | Edge Bronchoscope (Natural Orifice)

Edge Medical’s Bronchoscope Robot represents the company’s expansion beyond laparoscopic surgery into natural orifice transluminal endoscopic surgery (NOTES). Receiving NMPA approval in January 2025, this system navigates through natural airways using a flexible robotic endoscope designed specifically for diagnostic and therapeutic bronchoscopy procedures in the lung periphery.

Product Overview

The bronchoscope robot entered commercial use in China during September 2025, complementing Edge Medical’s existing portfolio of multi-port and single-port laparoscopic systems. Unlike the company’s core surgical robots that operate through incisions, this platform accesses target anatomy through natural body openings—specifically the respiratory tract.

Edge Medical’s NMPA approval for this bronchoscope system, combined with its earlier multi-port and single-port laparoscopic approvals, made the company the first in China and second globally to hold regulatory clearances across all three categories: multi-port, single-port, and natural orifice surgical robots.

Key Features

For peripheral lung biopsy, Edge Medical’s Bronchoscope Robot reaches distal bronchial segments through natural airways without incisions.

• Flexible Robotic Endoscope: Navigable scope designed for peripheral lung access through natural airways

• Peripheral Lung Navigation: Enables access to lung lesions in distal bronchial segments that may be difficult to reach with conventional bronchoscopes

• Natural Orifice Approach: No incisions required; entire procedure conducted through the patient’s airway

• Diagnostic Capability: Designed for tissue sampling and visualization of peripheral pulmonary nodules

Clinical Applications

The bronchoscope robot is designed for pulmonary medicine applications:

Diagnostic Bronchoscopy: Visualization and assessment of bronchial anatomy and peripheral lung abnormalities

Peripheral Lung Biopsy: Tissue sampling from lung nodules located in distal airways where conventional bronchoscopes have limited reach

Therapeutic Potential: Platform may support future therapeutic interventions in the lung periphery

Robotic bronchoscopy addresses a clinical challenge in pulmonary medicine: reaching and sampling small peripheral lung nodules detected on CT imaging. Traditional bronchoscopes have difficulty navigating the narrow, branching distal airways, while CT-guided percutaneous biopsy carries pneumothorax risk. Robotic systems aim to improve peripheral access through enhanced navigation and articulation.

Regulatory Status

Edge Medical began commercialization of the bronchoscope robot in China in September 2025. International regulatory submissions have not been announced as of the company’s January 2026 IPO.

Market Context

The robotic bronchoscopy market includes several established competitors. Intuitive Surgical’s Ion system and Auris Health’s (J&J) Monarch platform have gained traction in the United States. In China, multiple companies including Broncus Medical (堃博医疗) have developed bronchoscopy navigation and robotic systems.

Edge Medical’s bronchoscope robot is not designated as a core product in the company’s prospectus, which emphasizes the MP1000 and SP1000 laparoscopic platforms. However, the natural orifice capability broadens Edge Medical’s addressable market and demonstrates technical capabilities across multiple robotic surgery approaches.

Frequently Asked Questions

What is a natural orifice surgical robot?

Natural orifice transluminal endoscopic surgery (NOTES) robots access internal anatomy through natural body openings such as the mouth, nose, or other orifices, rather than through surgical incisions. Edge Medical’s bronchoscope robot enters through the patient’s airway to reach lung tissue.

What procedures can the bronchoscope robot perform?

The system is designed for diagnostic and therapeutic bronchoscopy procedures, primarily targeting peripheral lung lesions that are difficult to access with conventional flexible bronchoscopes. Common applications include biopsy of pulmonary nodules detected on CT imaging.

How does this compare to other robotic bronchoscopy systems?

The market includes systems from Intuitive Surgical (Ion), Auris Health/J&J (Monarch), and others. Edge Medical’s system has NMPA approval for the Chinese market; specific technical comparisons and clinical outcome data are limited at this early commercialization stage.